Science and Research

Clinical-radiological-pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms

Ever since the second world symposium on pulmonary hypertension (PH) held in Evian, France, in 1998, PH has been classified into five major clinical groups. Group 5 PH includes a variety of distinct conditions with unclear and/or multifactorial underlying pathologies. Management of these patients is challenging as the number of patients within these groups is often small, not all individuals with certain underlying conditions are affected by PH and patients exhibit distinct symptoms due to different underlying diseases. Studies and clinical trials in these groups are largely lacking and mostly restricted to case series and registry reports. Nonetheless, the worldwide burden of group 5 PH is estimated to be significant in terms of the prevalence of some associated diseases. Group 5 PH encompasses six subgroups, including haematological disorders (inherited and acquired chronic haemolytic anaemia and chronic myeloproliferative disorders), systemic disorders (sarcoidosis, pulmonary Langerhans's cell histiocytosis and neurofibromatosis type 1), metabolic disorders (glycogen storage diseases and Gaucher disease), chronic renal failure with or without haemodialysis, pulmonary tumour thrombotic microangiopathy and fibrosing mediastinitis.

  • Lichtblau, M.
  • Mayer, L.
  • Gopalan, D.
  • Dorfmüller, P.
  • Ulrich, S.

Keywords

  • Humans
  • *Hypertension, Pulmonary/diagnostic imaging/etiology
  • Prevalence
Publication details
DOI: 10.1183/16000617.0119-2023
Journal: Eur Respir Rev
Number: 170
Work Type: Original
Location: UGMLC
Disease Area: PH
Partner / Member: JLU
Access-Number: 38123234

DZL Engagements

chevron-down